Clinical Trials Directory

Trials / Completed

CompletedNCT02954068

IV Versus IM Administration of Oxytocin for Postpartum Bleeding

Intravenous Versus Intramuscular Administration of Oxytocin and Its Relationship With Postpartum Bleeding and Other Clinical Signs: a Randomized Placebo-controlled Study

Status
Completed
Phase
Phase 4
Study type
Interventional
Enrollment
543 (actual)
Sponsor
Gynuity Health Projects · Academic / Other
Sex
Female
Age
Healthy volunteers
Accepted

Summary

This double-blind, randomized controlled trial will evaluate the effect of the route of administration of 10 IU of oxytocin on the average blood loss postpartum. Participants will be randomized to receive 10 IU of oxytocin by IV infusion or 10 IU of oxytocin by injection IM

Conditions

Interventions

TypeNameDescription
DRUGIV Oxytocin + IM placebo
DRUGIM Oxytocin + IV placebo

Timeline

Start date
2016-12-01
Primary completion
2017-09-30
Completion
2017-10-01
First posted
2016-11-03
Last updated
2018-04-30

Locations

1 site across 1 country: Argentina

Source: ClinicalTrials.gov record NCT02954068. Inclusion in this directory is not an endorsement.